Top Polish pharmaceutical firm selects Vietnam for regional strategic market development

September 25, 2013 | 14:00
(0) user say
Today, Polpharma, a leader of Polish pharmaceutical market as well as the largest Polish manufacturer of medicines and pharmaceutical substances, officially announced their establishment of Vietnam business operation.


Polpharma Vietnam is established as a representative office of the company with a current portfolio of more than 600 products that have been well-known to patients and doctors around the world. 

“Vietnam, highly potential with a big population and a fast growing pharmaceutical industry, is becoming one of our most important emerging markets. Vietnam stands a strategic platform in our development strategy to reach other ASEAN markets,” said Rajmund I. Martyniuk, vice president of Polpharma Group’s board of directors and commercial director.

Heading Polpharma Vietnam is Davlet Matkerimow, who has 19 years of experience in pharmaceutical industry. His major success is establishment of representative offices in three important markets of Polpharma - Kazakhstan, Uzbekistan and Azerbaijan as well as custom warehouses in Kazakhstan, Uzbekistan and Georgia.

“We are looking for strategic partners and are open to any type of cooperation including partnership. Our aim is to introduce the European quality products to Vietnamese patients in order to help them to live their lives better and longer in good health. Among our development priorities, there is a possibility of starting production of our medicines here in Vietnam, transferring our knowledge, R&D and international quality standards,” said Matkerimow.

Polpharma is an international pharmaceutical group with revenues of about $1 billion, actively operating in the territory of European Union, Russia, Kazakhstan, Caucasus and Central Asia. The company is the leader of the Polish pharmaceutical market, as well as the largest Polish manufacturer of generic medicines.

All Polpharma products are made in accordance with international GMP standards using modern technologies guaranteeing the highest product quality and environmental safety. Besides of medicines, Polpharma provides number of API (active pharmaceutical ingredients) supplying leading pharmaceutical producers worldwide, including the US and Japan.

Polpharma’s motto is “People Helping People”. In 2001, Polpharma established a scientific foundation, supporting most interesting researches in the fields of pharmaceutics and medical science through scientific grants. Polpharma also finances scholarships for young scientists and activities of students’ scientific interest groups.

By By Hoang Anh

What the stars mean:

★ Poor ★ ★ Promising ★★★ Good ★★★★ Very good ★★★★★ Exceptional